Riskpilot← Back to searchSign inGet full accessXPANDIR SCANDINAVIA AS
ASActiveOrg 926741810Rambergveien 16B, 3115 TønsbergDevelopment of building projects · NACE 6812Est. 20213 employees
Revenue 2025
NOK 6,6M
+44% vs 2024
EBITDA margin
55.3%
+51% vs 2024
Equity ratio
75.6%
Financial strength
Net profit 2025
NOK 7,7M
+478% vs 2024
| Revenue | NOK 6,6M | +44% |
| EBITDA | NOK 3,7M | +51% |
| Net profit | NOK 7,7M | +478% |
| Total assets | NOK 15,9M | +90% |
| Equity | NOK 12M | +127% |
| Employees | 3 | — |
Legal name
XPANDIR SCANDINAVIA AS
Org number
926741810
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
8. mars 2021
Share capital
NOK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Eierskap og deltakelse i andre selskaper, eierskap og utvikling av eiendom, investering i aksjer, verdipapirer og det som ligger naturlig under slike aktiviteter
Address
Rambergveien 16B, 3115 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 699 | 14 234 | 16 002 | 4 591 | 6 620 |
| Staff expenses | −2 | −528 | −1 603 | −1 771 | −2 527 |
| EBITDA | −112 | −277 | 2 428 | 2 419 | 3 662 |
| Depreciation & amort. | −22 | −89 | −89 | −89 | −89 |
| EBIT | −134 | −366 | 2 339 | 2 330 | 3 573 |
| Net financials | 1 306 | −50 | 2 110 | −497 | 5 021 |
| Profit before tax | 1 172 | −416 | 4 448 | 1 833 | 8 594 |
| Tax | −0 | −0 | 391 | 500 | 883 |
| Net profit | 1 172 | −416 | 4 058 | 1 333 | 7 711 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 266 | 5 157 | 7 527 | 8 353 | 15 884 |
| Equity | 1 217 | 700 | 4 358 | 5 291 | 12 002 |
| Long-term debt | 2 000 | 2 160 | 2 000 | 1 650 | 0 |
| Short-term debt | 49 | 2 296 | 1 169 | 1 412 | 2 532 |
| Total debt | 2 049 | 4 456 | 3 169 | 3 062 | 3 882 |
EBITDA margin
55.3%
This company
15.8%
Market median
+250% vs market
20212025
Equity ratio
75.6%
This company
38.2%
Market median
+98% vs market
20212025
Return on equity
64.2%
This company
18.4%
Market median
+249% vs market
20212025
Net profit margin
116.5%
This company
8.1%
Market median
+1338% vs market
20212025
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TA Chief Executive Officer | Chief Executive Officer | 2021 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
XPANDIR SCANDINAVIA AS 
Helsegruppen AsBoard members of XPANDIR SCANDINAVIA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Andre Skulbru | Chief Executive Officer | 0 companies |